Amicoumacin A induces cancer cell death by targeting the eukaryotic ribosome
Amicoumacin A is an antibiotic that was recently shown to target bacterial ribosomes. It affects translocation and provides an additional contact interface between the ribosomal RNA and mRNA. The binding site of amicoumacin A is formed by universally conserved nucleotides of rRNA. In this work, we showed that amicoumacin A inhibits translation in yeast and mammalian systems by affecting translation elongation. We determined the structure of the amicoumacin A complex with yeast ribosomes at a resolution of 3.1 Å. Toxicity measurement demonstrated that human cancer cell lines are more susceptible to the inhibition by this compound as compared to non-cancerous ones. This might be used as a starting point to develop amicoumacin A derivatives with clinical value.
Citations by journals
1
2
3
|
|
Frontiers in Microbiology
|
Frontiers in Microbiology
3 publications, 7.89%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
3 publications, 7.89%
|
Biochemistry (Moscow)
|
Biochemistry (Moscow)
3 publications, 7.89%
|
Biochimie
|
Biochimie
2 publications, 5.26%
|
European Journal of Organic Chemistry
|
European Journal of Organic Chemistry
2 publications, 5.26%
|
Nature Chemical Biology
|
Nature Chemical Biology
1 publication, 2.63%
|
Molecules
|
Molecules
1 publication, 2.63%
|
Organic Letters
|
Organic Letters
1 publication, 2.63%
|
Antibiotics
|
Antibiotics
1 publication, 2.63%
|
Cancers
|
Cancers
1 publication, 2.63%
|
Pharmaceutics
|
Pharmaceutics
1 publication, 2.63%
|
Chemistry of Natural Compounds
|
Chemistry of Natural Compounds
1 publication, 2.63%
|
Scientific Reports
|
Scientific Reports
1 publication, 2.63%
|
Cell Chemical Biology
|
Cell Chemical Biology
1 publication, 2.63%
|
Current Opinion in Green and Sustainable Chemistry
|
Current Opinion in Green and Sustainable Chemistry
1 publication, 2.63%
|
Journal of Drug Delivery Science and Technology
|
Journal of Drug Delivery Science and Technology
1 publication, 2.63%
|
Biomedicine and Pharmacotherapy
|
Biomedicine and Pharmacotherapy
1 publication, 2.63%
|
Molecular Cell
|
Molecular Cell
1 publication, 2.63%
|
Angewandte Chemie
|
Angewandte Chemie
1 publication, 2.63%
|
Angewandte Chemie - International Edition
|
Angewandte Chemie - International Edition
1 publication, 2.63%
|
ChemMedChem
|
ChemMedChem
1 publication, 2.63%
|
Journal of Natural Products
|
Journal of Natural Products
1 publication, 2.63%
|
Natural Product Reports
|
Natural Product Reports
1 publication, 2.63%
|
Organic Chemistry Frontiers
|
Organic Chemistry Frontiers
1 publication, 2.63%
|
Nucleic Acids Research
|
Nucleic Acids Research
1 publication, 2.63%
|
Biophysics (Russian Federation)
|
Biophysics (Russian Federation)
1 publication, 2.63%
|
Bulletin of Russian State Medical University
|
Bulletin of Russian State Medical University
1 publication, 2.63%
|
Studies in Natural Products Chemistry
|
Studies in Natural Products Chemistry
1 publication, 2.63%
|
Biopolymers and Cell
|
Biopolymers and Cell, 1, 2.63%
Biopolymers and Cell
1 publication, 2.63%
|
1
2
3
|
Citations by publishers
1
2
3
4
5
6
7
8
|
|
Elsevier
|
Elsevier
8 publications, 21.05%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 18.42%
|
Wiley
|
Wiley
5 publications, 13.16%
|
Pleiades Publishing
|
Pleiades Publishing
4 publications, 10.53%
|
Springer Nature
|
Springer Nature
3 publications, 7.89%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
3 publications, 7.89%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
2 publications, 5.26%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
2 publications, 5.26%
|
Oxford University Press
|
Oxford University Press
1 publication, 2.63%
|
Pirogov Russian National Research Medical University
|
Pirogov Russian National Research Medical University
1 publication, 2.63%
|
Naukova Dumka
|
Naukova Dumka, 1, 2.63%
Naukova Dumka
1 publication, 2.63%
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.